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Background: The fruit Terminalia belerica is a rich source of vitamins, acids, and nutraceuti-
cals  which have free radical scavenging activity. Thus, the ethanolic extract of fruit and its
isolated compound (Tb-01) were intended to estimate antiplatelet and antioxidant activities.
Methods: The ethanolic extract was submitted to Si-gel CC and the compound was isolated.
The  compound Tb-01 was characterized as benzoyl-ˇ-D-(4′→10′′ geranilanoxy)-pyranosides
on  the basis of spectral data [ultra violet (UV), infrared (IR), 1H nuclear magnetic resonance
(NMR), 13C NMR, and Mass Spectroscopy] and chemical analyses. The ethanolic extract and
Tb-01 at different concentrations were in vitro screened for antiplatelet and antioxidant
activity. The antiplatelet activity was carried out by using platelet rich plasma prepared by
centrifugation of rabbit whole blood (containing 0.9% sodium citrate as anticoagulant) and
antioxidant activity using 1,1-diphenyl-2-picrylhydrazyl, reducing power, and nitric oxide
anion scavenging activity models.
Results: The compound Tb-01 was an amorphous brownish powder, yield 0.64% (w/w),
melting point 105–110 ◦C, Retardation factor/Retention Value (Rf value) at 0.42 in
methanol:chloroform (20:80) solvent system, UV absorption maxima at 243 nm, and molec-
ular peak [M + H]+ at 394.15 m/z. It was observed that the ethanolic extract and Tb-01
at  different concentrations showed signiﬁcant antiplatelet and antioxidant activity. The
antioxidant activity, like scavenging of 1,1-diphenyl-2-picrylhydrazyl radicals, nitric oxide
radical, and reductive power were found to be concentration-dependent and increased when
increasing amounts of sample were used.
Conclusion: Mass spectra and 1H NMR conﬁrmed the isolated compound structure which wassupported by 13C NMR and IR spectra. Tb-01could be promising for future applications in
the  treatment of blood clots, pulmonary embolism, and other related diseases.
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1.  Introduction
Blood platelets are the cell remains, which prevents exces-
sive hemorrhage by forming blood clots.1 The blood clot is a
mass of blood cells and blood components which are formed to
prevent bleeding resulting from blood vessel injury. In this pro-
cess, platelets in the blood become sultry and clump together
at the site of injury. Clotting is the body’s normal response
to prevent a person from hemorrhaging to death.2 However,
blood clot formation can be hazardous if it occurs well within
blood vessels, or if not violated after due time. Serious diseases
like heart attacks and pulmonary embolisms are connected
with the unfortunate blood clot formation.3,4 There are some
synthetic blood thinners like aspirin and heparin present in
the market; these synthetic drugs have many  side effects
like ulceration and gastrointestinal problems.5 Herbal prod-
ucts can be isolated and identiﬁed as potential antiplatelet
medicines.6
Terminalia belerica (Roxb.) f. (Combretaceace) is cultivated
in the east and northeast region of India, particularly in
Assam, West Bengal, Uttar Pradesh, Bihar, Tamil Nadu, and
Karnataka. The plant fruit is one of the main ingredients
of the well-known preparation “Triphala”, which is used in
for the treatment of the common cold, pharyngitis, consti-
pation, headache, leucorrhoea, liver diseases, gastrointestinal
complaints, and hair loss.7 It is a powerful adaptogenic plant
fruit that nourishes the lungs, eyes, throat, voice, and hair.8 It
expels stones or other kapha-type accumulations in the uri-
nary, digestive, and respiratory tracts.9 It has powerful laxative
and astringent properties, it purges the bowels and simulta-
neously tones the tissues of the digestive tract, and it also
provides potency to the tissues of the sense organs.10 Phar-
macological evaluations of the fruits have indicated them
to have anthelmintic, antidiarrheal, antiseptic, astringent,
expectorant, antidiabetic,11 rejuvenative, and hepatoprotec-
tive effects.12 The overall tonic potential of these fruits has
been known for thousands of years in India and Asian coun-
tries. Phytochemical investigation of T. belerica fruits showed
the presence of ellagic acid, ethyl gallate, galloyl glucose, lig-
nans (termilignan), chebulagic acid, phyllemblin, ˇ-sitosterol,
glucoside (bellericanin), gallo-tannic acid, mannitol, glucose,
fructose, rhamnose, coloring matter, resins, and greenish yel-
low oil.13 The fruit of this plant is a rich source of vitamins,
acids and nutraceuticals which have free radical scavenging
activity.14 Free radicals like nitric oxide (NO) and superox-
ide (O2−) are implicated in the pathophysiology of different
ailments.15 The present paper describes the isolation and
characterization of 4′-substituted benzoyl-ˇ-D glycoside from
the ethanolic extract of T. belerica fruit and it is investigated
for antiplatelet and antioxidant activity.
2.  Methods
2.1.  Collection  and  authentication  of  plant  specimenThe mature fruits of T. belerica were procured in July 2013 from
a local market in Lucknow, Uttar Pradesh, India and authenti-
cated by Dr. Tarique Husain Botanist, at the National BotanicalIntegr Med Res ( 2 0 1 6 ) 317–323
Research Institute, Lucknow. A voucher specimen No-95482
was retained in this laboratory for further reference.
2.2.  Extraction  and  isolation
The fruits were dried in shade under a hot air blower and pow-
dered. The fruit powder (200 g) was defatted with petroleum
ether and extracted with ethanol using Soxhlet apparatus. The
ethanolic extract was then concentrated and dried to yield
21.63% w/w. The ethanolic extract (25 g) was submitted to SiO2
gel CC eluting petroleum ether, chloroform, and methanol to
afford 46 fractions. The compound was isolated from frac-
tions 18–23 (chloroform:methanol 80:20) and subjected to
thin layer chromatography using the solvent system chloro-
form:methanol (8:2) which showed a single spot at Rf value of
0.42 detected by spraying with anisaldehyde sulfuric acid. This
fraction was collected and dried to get 160 mg of amorphous
brownish powder with a melting point of 105–110 ◦C which
was  coded as Tb-01.16
2.3.  Instrumentation  and  chemicals
UV spectra scanned in methanol on a Lambda Bio 20 spec-
trophotometer (Shimadzu-U, Singapore). IR spectra were
recorded in KBr pellets on a Win IR FTS 135 instrument
(Biorad, Philadelphia, PA, USA). 1H nuclear magnetic reso-
nance (NMR) (300 MHz) and 13C NMR  (75 MHz) spectra were
recorded on a Brucker spectrometer (Brucker, Billerica, MA,
USA) in Deuterated methanol (MeOD) with Tetramethyl silane
(TMS) as internal standard. The Mass Spectroscopy were mea-
sured on a JEOL-AccuTOF machine, Ambala, Haryana, India
equipped with a Direct Analysis in Real Time (DART) ion
source and helium was used as a gas of collision. Melting
points were determined on Perﬁt melting point apparatus,
Ambala, Haryana, India. Silica gel (60–120 mesh, Qualigens,
Mumbai, India) was used for column chromatography. Silica
gel G (Qualigens) was used for analytical thin layer chromatog-
raphy. Spots were visualized by exposure to iodine vapors,
a UV lamp (254 nm), and by spraying with anisaldehyde
sulfuric acid reagents. 1,1-Diphenyl-2-picrylhydrazyl (DPPH,
Sigma-Aldrich, Bangalore, Karnataka, India). The solvents for
isolation were obtained from Merck Mumbai, India.
2.4.  Blood  specimen
Whole blood was drawn from healthy rabbits of both sexes
aged 20 weeks of the race Cunistar and New Zealander, with
an average mass of 2.2 kg. The required volume of blood was
taken into each of the microcentrifuge tubes. The experi-
mental protocol was approved by the Institutional Ethical
Committee (approval number IU/Pharm/Ph.D./CPCSEA/10/03)
following the guidelines of the Committee for the Purpose
of Control and Supervision of Experiments on Animals (CPC-
SEA) which complies with international norms of the Indian
National Science Academy.2.5.  Antiplatelet  activity
Platelet rich plasma (PRP) was prepared by centrifugation
of rabbit whole blood (containing 0.9% sodium citrate as
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The free radical scavenging capacity of Tb-01, ethanolic
extract, and ascorbic acid against DPPH radical was evaluated.A. Ansari et al/New 4′– substituted benzoyl-ˇ-D glycoside from the Ter
nticoagulant) at 252 g for 15 minutes. The concentration
f PRP was adjusted to optical density 1.0 at  400 nm by
dding normal saline and 1 mL of PRP was taken in each
f nine tubes. Tubes 2–9 contained different concentra-
ions (1.0 g/mL, 2.0 g/mL, 3.0 g/mL, 4.0 g/mL, 5.0 g/mL,
.0 g/mL, 7.0 g/mL, and 8.0 g/mL, respectively) of isolated
ompound (Tb-01), ethanolic extract, and aspirin, and Tube 1
ontained normal saline solution as a blank. The ﬁnal volume
f each tube was adjusted up to 2 mL  by adding normal
aline solution. All of these tubes were incubated at 37 ◦C
or 3 minutes and then 0.2 mL  of collagen 2 g/mL was added
n to each tube. Aggregation was induced under continuous
tirring at 112 g for 3 minutes. The aggregation was monitored
nder a spectrophotometer at  400 nm.17,18
.6.  Antioxidant  activity
he radical scavenging activities of the ethanolic fruit extracts
nd Tb-01 against DPPH were determined. An aliquot of
0.4 mg/mL, 0.6 mg/mL, 0.8 mg/mL, 1.0 mg/mL, and 1.2 mg/mL)
f extract and Tb-01 was mixed in a test tube containing 3 mL
f methanol and 0.5 mL  of 1 mM DPPH. Ascorbic acid was used
s the antioxidant standard at the same concentrations and
 blank solution was prepared containing the same amount
f methanol and DPPH. The reaction mixture was incubated
t 37 ◦C for 30 minutes, and absorbance of the chromophore
ormed was read using a UV spectrophotometer at 517 nm.19
he radical scavenging activity was calculated using the fol-
owing equation:
 scavenging = (Ac − At)/Ac × 100%,
here Ac is the absorbance of control and At is the absorbance
f the test sample.
.7.  Nitric  oxide  anion  scavenging  activity
n aliquot 1 mL  of extract, Tb-01, and ascorbic acid (0.4 mg/mL,
.6 mg/mL, 0.8 mg/mL, 1.0 mg/mL, and 1.2 mg/mL  in methanol)
as mixed in 1 mL  of sodium nitroprusside (10 mM)  in phos-
hate buffered saline and incubated at room temperature
or 180 minutes. The reaction does not have test sample
ut equivalent amount of methanol served as control. After
he incubation period, 0.5 mL  of Greiss reagent (1% sulfanil-
mide, 2% phosphoric acid, and 0.1% naphthylenediamine
ihydrochloride) was added. Ascorbic acid was used as a pos-
tive control and absorbance of the chromophore formed was
ead by a UV spectrophotometer at 546 nm.15
.8.  Reducing  power
he ethanolic extract, Tb-01 and gallic acid at concen-
rations of 0.4 mg/mL, 0.6 mg/mL, 0.8 mg/mL, 1.0 mg/mL,
nd 1.2 mg/mL  in distilled water were mixed with 2.5 mL
hosphate buffer (0.2 mM,  pH 6.6) and 1% of 2.5 mL  potas-
ium ferricyanide. The mixture was incubated at 45 ◦C for
0 minutes. Subsequently, 2.5 mL of trichloroacetic acid (10%)
as added to the mixture, which was then centrifuged for
0 minutes at 700 g. The upper layer of the solution (1.5 mL)
as mixed with 1.5 mL  distilled water and FeCl3 (0.3 mL,  0.1%)ia belerica with antiplatelet and anti-oxidant potency 319
and the absorbance was measured at 700 nm using a UV-VIS
spectrophotometer.20
2.9.  Statistical  analysis
The experiment results are expressed as the mean ± standard
deviation and IC50 values were calculated by linear regression
analysis for antioxidant activity. One-way analysis of variance
followed by Dunnett test was performed by using Graph Pad
Prism 2.01 (Graph Pad Software, Inc., San Diego,  CA,  USA) for
antiplatelet activity and a value of p < 0.05 and p < 0.01 were
considered as statistically signiﬁcant.21
3.  Results
3.1.  Structural  elucidation  of  isolated  compound
(Tb-01)
Amorphous brownish powder; yield 0.64% (w/w); melting
point 105–110 ◦C; Rf 0.42 (CHCl3:MeOH, 80:20); UV-visible max
nm (CH3OH):243; IR max (KBr):OH (str) 3401; Ali C-H (str) 2926;
C=C 1525; C-O (pyran) 1646; OH (bend) 1215; C-C (str) 758 cm-1;
1H-NMR (300 MHz, MeOD) and 13C-NMR (75 MHz, MeOD) (spec-
tral data: Table 1); MS  DART m/z (Direct Analysis in Real Time
intense): 394.15 [M]+ (C22H34O6), 237.06,141.14 and 162.13.
3.2.  Antiplatelet  activity  testing
T. belerica showed very good antiplatelet activity in both Tb-01
and ethanolic extracts. It was observed that both the Tb-
01 and ethanolic extract, at different concentrations, showed
signiﬁcant antiplatelet activity when compared with the con-
trol group. The maximum antiplatelet activity was observed
between the concentrations 5–8 g/mL (p < 0.01). The ethano-
lic extract showed less potency than Tb-01 and both were more
potent than the aspirin (Fig. 1).
3.3.  Antioxidant  activityFig. 1 – Comparative antiplatelet activity of Tb-01, ethanolic
extracts, and aspirin at different concentrations. Each value
expressed percentage of antiplatelet activity at different
increasing concentrations.
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Table 1 – 1H and 13C-nuclear magnetic resonance (NMR)  spectral values of 4′-substituted benzoyl-ˇ-D glycoside (Tb-01).
Position of proton Nature of proton ıH (ppm) ıC (ppm)
 ˛ ˇ
C1 C – – 146.49
C2 CH 7.52 (m) – 139.69
C3 CH 7.08 (m) – 123.48
C4 CH 6.98 (m) – 110.43
C5 CH 7.05 (m) –  118.37
C6 CH 7.46 (m) –  122.06
C7 C=O – – 170.51
C1′ CH 4.67 (d, J = 7.2 Hz) – 90.31
C2′ CH 4.38 (m) – 75.08
C3′ CH 3.74 (m) – 69.84
C4′ CH 4.04 (m) – 73.97
C5′ CH2 3.56 (d, J = 4.8 Hz) 3.52 (d, J = 5.7 Hz) 64.51
C1′′ CH3 0.86 (t, J = 6.5 Hz) – 13.18
C2′′ CH2 1.19 (m) 1.15 (m) 22.03
C3′′ CH2 2.58 (m) 2.59 (m) 46.34
C4′′ CH2 2.50 (m) 2.53 (m) 30.16
C5′′ CH2 2.56 (m) 2.48 (m) 36.27
C6′′ CH2 2.11 (m) 2.07 (m) 38.89
C7′′ CH 2.90 (m) – 42.18
C8′′ CH3 1.27 (d, J = 5.4 Hz) – 15.07
7 (d, 
1 (d, C9′′ CH3 1.3
C10′′ CH2 3.3
and they showed a dose-dependent radical scavenging activ-
ity. The drugs showed maximum inhibition at 1.2 mg/mL. The
calculated IC50 value of Tb-01, extract, and ascorbic acid were
0.62 ± 0.06 mg/mL, 0.76 ± 0.12 mg/mL, and 0.48 ± 0.08 mg/mL,
respectively (Fig. 2).
3.4.  Nitric  oxide  anion  scavenging  activity
Fig. 3 shows the ability of Tb-01, ethanolic extract, and
ascorbic acid to quench NO• radicals in dose-dependent man-
ner and maximum inhibition was obtained at 1.20 mg/mL.
The IC50 values of Tb-01, ethanolic extract, and ascor-
bic acid were 0.069 ± 0.014 mg/mL, 0.082 ± 0.018 mg/mL, and
0.058 ± 0.012 mg/mL, respectively.
Fig. 2 – Dose-dependent scavenging of
1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals by ascorbic
acid, Tb-01, and ethanolic extract. The data represent the
percentage scavenging of DPPH radicals. Each value
represents mean ± standard deviation (n = 4).J = 6.4 Hz) – 17.38
J = 6.1 Hz) 3.34 (d, J = 6.1 Hz) 62.65
3.5.  Reducing  power
Fig. 4 shows the reductive capabilities of the different con-
centrations of Tb-01, ethanolic extract, and gallic acid. The
reducing power of tested drugs was increased as the con-
centrations increased. At the highest dose of 1.2 mg/mL, the
absorbance of Tb-01, ethanolic extract, and gallic acid were
0.848, 0.714, and 0.973, respectively.
4.  Discussion
The compound Tb-01 was obtained as an amorphous brown-
ish powder from the chloroform-methanol (80:20) eluent. It
gave positive Fehling’s test for glycosides and showed IR
absorption band for hydroxyl groups (3,401/cm), unsaturation
Fig. 3 – Nitric oxide radical scavenging activity of ascorbic
acid, Tb-01, and ethanolic extract at different concentration.
The data represent the percentage nitric oxide inhibition.
Each value represents mean ± standard deviation (n = 4).
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Fig. 4 – The reductive ability of gallic acid, Tb-01 and
ethanolic extract at different concentration. The absorbance
(A700) was plotted against concentration of sample. Each
value represents mean ± standard deviation (n = 4).
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Fig. 5 – Benzoyl-ˇ-D-(4′→10′′ geranilanoxy)-pyranosides.=C aromatic group (1,525/cm), benzoyl C-O group (1,646/cm),
nd aliphatic chain (758/cm). Absorption band 3401/cm arises
rom polymeric structures of hydrogen in hydroxyl groups
nd another strong band appears around 2,926/cm assigned
o the linear vibration of hydrogen in C-H groups of the com-
ound. Vibration of a C-O linkage has been shown to produce
n absorption band at 1,646/cm, supporting the presence of a
enzoyl group in the compound.22
On the basis of mass and 13C NMR  spectra, the radical
olecular ion of Tb-01 found at m/z 394.15 [M]+ was consistent
o the molecular formula C22H34O6. The 1H NMR  spectrum of
b-01 showed one single proton doublet at ıH 4.67 (J = 7.2 Hz)
ssigned to anomeric proton H-1′ of sugar attached to the ben-
oyl group and other sugar methine protons from ıH 4.38 to
.74. The multiplet signal at ıH 4.04 ppm indicates the pres-
nce of methine proton of sugar at C-4′ and coupled with
-5  ˛ and H-5ˇ. The methine proton (CH) which is in a highly
eshielded environment, gives multiplet signals at ıH 7.52,
.08, 6.98, 7.05, and 7.46 which were accounted to the presence
f benzoyl groups. The gem dimethyl protons of the geranyl
roup give a triplet signal at ıH 0.88 (J = 6.5 Hz) and other two
ethyl protons showed doublet at ıH 1.27 (d, J = 5.4 Hz) and 1.37
Table 2 – Antiplatelet activity of Tb-01 and ethanolic extract of T
Test tube No. Conc. of drugs (g/mL) 
1. 0.0 0.12
2. 1.0 0.23
3. 2.0 0.36
4. 3.0 0.46
5. 4.0 0.58
6. 5.0 0.67
7. 6.0 0.78
8. 7.0 0.83
9. 8.0 0.91
Data were expressed as mean ± standard deviation (n = 3). One-way analys
*p < 0.05 and **p < 0.01 compared with resting platelets (control).
1 mL of diluted platelet rich plasma and 0.2 mL of collagen (2 g/mL) were (d, J = 5.4 Hz). The 13C NMR spectrum exhibited aglycone ester
carbonyl carbon at ıC 170.51 (C-7), aromatic carbons at ıC 1-6
146.49, 139.69, 123.48, 110.43, 118.37, and 122.06, one anomeric
sugar carbon at ıC 90.31 (C-1′) and other sugar carbons at
ıC 90.31– 64.51. The methyl carbon (CH3) give signals at ıC
13.18, 15.07, and 17.38.23 The compound shows a typical frag-
mentation pattern with molecular ions and a few fragment
ions. MS of Tb-01 exhibited major ion fragments generated
at m/z  394.15 (C22H34O6), 237.06 (C12H14O5 glucose esteriﬁed
with benzene), 141.14 [C10H22 (2,6-dimethyloctane) aglycon
geranyl] and 162.13 (C6H11O5 pyran). On the basis of these
results, the structure of Tb-01 was characterized as benzoyl-
ˇ-D-(4′→10′′ geranilanoxy)-xylopyranosides (Fig. 5).
The present study of antiplatelet activity of T. belerica was
carried out by the UV spectrophotometric method. Colla-
gen was taken as platelet aggregation inducer. The positive
(aspirin) and negative (Normal Saline) controls clearly revealed
the appropriateness of the methods under investigation.
These results show that in vitro, the Tb-01 and ethanol extract
inhibit collagen-induced platelet aggregation in a concen-
tration dependent manner. Therefore, they have power to
prevent thrombotic or cardiovascular disease. The principle
of the method is when an agonist (collagen) was added in
PRP, the platelets aggregated and settled down, and hence
absorbed less light, so the transmission increased; this was
then detected by the photocell (Table 2). The working concen-
tration of collagen was taken as 2 g/mL and 0.2 mL  of collagen
was used for each tube, as this was the optimized amount
erminalia belerica fruit
Optical density
Tb-01 Ethanolic ext. Aspirin
1 ± 0.023 0.121 ± 0.023 0.121 ± 0.023
2 ± 0.017 0.198 ± 0.014 0.164 ± 0.023
3 ± 0.028* 0.278 ± 0.017 0.186 ± 0.028
1 ± 0.025* 0.381 ± 0.023* 0.242 ± 0.019
2 ± 0.017* 0.464 ± 0.014* 0.322 ± 0.024*
6 ± 0.028** 0.521 ± 0.017** 0.384 ± 0.026*
1 ± 0.019** 0.596 ± 0.023** 0.434 ± 0.017*
4 ± 0.016** 0.651 ± 0.019** 0.514 ± 0.024**
7 ± 0.026** 0.728 ± 0.021** 0.587 ± 0.018**
is of variance was performed followed by Dunnett test.
taken in each tube.
r322  
and referred from published work. Comparative antiplatelet
activities of Tb-01, ethanolic extracts, and aspirin at different
concentrations are shown in Fig. 1.
In this study, the isolated glycoside Tb-01 may be
hydrolyzed to benzoic acid and geraniol, which have similar
activity to salicylates (aspirin). The effect of aspirin on platelet
function is to inactivate a key platelet enzyme cyclooxygenase
by diffusing into the cyclooxygenase channel in the membrane
to the catalytic site for the enzyme. Aspirin has a vital role in
the prevention of thromboembolic problems from atheroscle-
rotic disease.24 In addition, we further investigated whether
this efﬁcacy of Tb-01 in vitro is implemented in in vivo func-
tion.
Free radicals have been involved in many  disease condi-
tions, the important ones being NO, superoxide, hydroxyl,
and peroxyl radical. In the present study, Tb-01 and ethanolic
extract of T. belerica fruits were investigated for antioxidant
activity based on the response obtained in in vitro models.
DPPH is one of the free radicals used for testing the preliminary
radical scavenging activity. Both Tb-01 and ethanolic extract
of fruit showed a good antiradical activity by scavenging DPPH
radicals (Fig. 2).
NO exhibits abundant physiological properties and is impli-
cated in several pathological states.15 It is produced in various
cells including neurons, endothelial cells, and neutrophils.
The contact of NO with other radicals leads to the creation of
more hazardous radicals such as peroxy nitrite anion. Tb-01
and the ethanolic extract showed dose-dependent NO scav-
enging activity (Fig. 3).
The reducing capacity of a compound provides a signiﬁcant
indicator of its potential antioxidant activity. The reductive
capabilities of Tb-01 and ethanolic extract were compared
with gallic acid (Fig. 4). For the measurements of the reduc-
tive capacity, we  investigated the Fe3+ to Fe2+ transformation
in the presence of Tb-01 and the ethanolic extract.
A new (Tb-01) 4′-substituted ˇ-D glycoside (benzoyl-ˇ-
D-(4′→10′′ geranilanoxy)–xylopyranosides) has been isolated
from the ethanolic extract of T. belerica fruits. In antiplatelet
assays using freshly isolated rabbits platelets, the Tb-01 and
ethanolic extracts showed signiﬁcant inhibition of collagen-
induced platelet aggregation. We propose that the inhibitory
effects of Tb-01 and ethanolic extract on collagen-induced
platelet aggregation might inhibit collagen-stimulated platelet
aggregation without any toxicity. The DPPH, NO radical scav-
enging, and reducing capacity of Tb-01 and ethanolic extracts
were evaluated, which might be helpful in preventing or slow-
ing the progress of various oxidative stress related diseases,
and could be a promising strategy in many  cardiovascular
diseases such as atherosclerosis, myocardial infarction, and
thrombosis.
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